Teleflex, Inc. Stock Plummets to New 52-Week Low of $102.58

Teleflex, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 102.58 as of November 6, 2025. This marks a significant decline, with the stock's performance over the past year showing a decrease of 47.6%, contrasting sharply with the S&P 500's gain of 17.53% during the same period.
The company's market capitalization stands at approximately USD 5,892 million, and it currently has a price-to-earnings (P/E) ratio of 13.00. Teleflex offers a dividend yield of 1.08% and maintains a debt-to-equity ratio of 0.38, indicating a relatively low level of debt. However, the company has faced challenges in long-term growth, with net sales and operating profit increasing at annual rates of only 3.78% and 3.08%, respectively, over the last five years.

Despite these hurdles, Teleflex has shown some positive financial metrics, including a high interest coverage ratio of 979.3 and a return on equity of 11.18%. However, the stock's performance has consistently lagged behind the benchmark S&P 500, raising questions about its market position and future trajectory.